|
Jun 30
|
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
|
|
Jun 27
|
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 2.5% for Week
|
|
Jun 25
|
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU
|
|
Jun 25
|
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
|
|
Jun 25
|
Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag
|
|
Jun 25
|
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
|
|
Jun 24
|
Sector Update: Health Care Stocks Advance Late Afternoon
|
|
Jun 24
|
Sector Update: Health Care Stocks Higher in Afternoon Trading
|
|
Jun 24
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jun 24
|
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
|
|
Jun 24
|
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
|
|
Jun 19
|
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma
|
|
Jun 16
|
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
|
|
Jun 10
|
Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
|
Jun 10
|
Best Momentum Stocks to Buy for June 10th
|
|
Feb 19
|
Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025
|
|
Oct 9
|
Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
|
|
Oct 1
|
Amarin Announces Two Upcoming Investor Events
|
|
Aug 22
|
Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress
|
|
Jul 23
|
Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
|